Evidence map›Paper›PMID 28584138›Full record

ArticleAntimicrobial agents and chemotherapy2017

Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?

Audrey Le, Dimitrios Farmakiotis, Jeffrey J Tarrand, Dimitrios P Kontoyiannis

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Audrey LeDepartment of Internal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.ORCID 0000-0001-5525-4524
Dimitrios FarmakiotisDivision of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA dimitrios.farmakiotis@lifespan.org dkontoyi@mdanderson.org.
Jeffrey J TarrandDepartment of Laboratory Medicine, the University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Dimitrios P KontoyiannisDepartment of Infectious Diseases, Infection Control and Employee Health, the University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA dimitrios.farmakiotis@lifespan.org dkontoyi@mdanderson.org.
Brown University · USThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 28-day crude mortality rate in 68 cancer patients with fluconazole-susceptible dose-dependent

Indexed as

Amphotericin BAntifungal AgentsAzolesCandida glabrataCandidemiaDrug Resistance, FungalEchinocandinsFemaleFluconazoleHumansMaleMiddle AgedNeoplasmsPolyenesRetrospective StudiesAmphotericin BAntifungal AgentsAzolesEchinocandinsFluconazoleliposomal amphotericin BPolyenesazole monotherapyCandida glabratacandidemiaechinocandinpolyenes

Identifiers

PMID28584138
PMCPMC5527607
OpenAlexW2624171609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.